Viewing Study NCT02689232


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2026-01-11 @ 11:43 AM
Study NCT ID: NCT02689232
Status: COMPLETED
Last Update Posted: 2018-11-28
First Post: 2016-02-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed.
Sponsor: Institute of Liver and Biliary Sciences, India
Organization:

Study Overview

Official Title: TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed: An Open Label Randomized Controlled Trial.
Status: COMPLETED
Status Verified Date: 2018-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: All patients with non variceal bleed who are admitted under the Department of Hepatology at Institute of Liver and Biliary Sciences, who meet the inclusion criteria and who provide informed consent.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: